DYS1/ FR0014003TT8 /
27/05/2024 13:01:35 | Var. -0.2100 | Volume | Denaro17:35:43 | Lettera17:35:43 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
38.8700EUR | -0.54% | 300 Fatturato: 11,662.6000 |
38.6600Quantità in denaro: 75 | 39.0400Quantità in lettera: 75 | 51.09 bill.EUR | 0.59% | 48.58 |
Newsfile Corp
17:48
Your House Group Confirms an Increase in the Growth of the Rental Market in Mallorca, Spain
GlobeNewswire
17:44
MASI LOSS ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Masimo Corporation Investors to Inquir...
GlobeNewswire
17:38
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages DoubleVerify Holdings, Inc. Investors to Inquire About Se...
GlobeNewswire
17:37
Victory Square Announces $GAME Token to Launch June 3, Promoted by Major Sports Leagues & Influencer...
GlobeNewswire
17:33
NATIONALLY RANKED ROSEN LAW FIRM Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Bef...
GlobeNewswire
17:25
ROSEN, LEADING INVESTOR COUNSEL, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before...
GlobeNewswire
17:21
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Globe Life Inc. f/k/a Torchmark Corporation Investors t...
GlobeNewswire
17:00
NARI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Inari Medical, Inc. Investors ...
GlobeNewswire
17:00
CKPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Checkpoint Therapeutics, Inc. ...
GlobeNewswire
17:00
SPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sprout Social, Inc. Investors w...
GlobeNewswire
16:31
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Altimmune, Inc. Investors to Secure Counsel Before Imp...